Simultaneous determination of danshensu, ferulic acid, cryptotanshinone and tanshinone IIA in rabbit plasma by HPLC and their pharmacokinetic application in danxiongfang

被引:47
作者
Li, Xiaoli [1 ]
Li, Xiaorong [1 ]
Wang, Lijuan [1 ]
Li, Yuhang [1 ]
Xu, Yanxia [1 ]
Xue, Ming [1 ]
机构
[1] Capital Med Univ, Sch Chem Biol & Pharmaceut Sci, Dept Pharmacol, Beijing 100069, Peoples R China
基金
北京市自然科学基金;
关键词
danshensu; ferulic acid; cryptotanshinone; tanshinone IIA; quantification; pharmacokinetics; HPLC;
D O I
10.1016/j.jpba.2007.04.033
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A selective and sensitive reversed-phase high performance liquid chromatography method was developed and validated for the simultaneous determination of danshensu, ferulic acid, cryptotanshinone, and tanshinone IIA in rabbit plasma using p-hydroxybenzoic acid as internal standard. Liquid-liquid extraction was used for sample preparation. Chromatographic separation was successfully achieved on an Agilent HC-C-18 column using a mobile phase composed of methanol-water (from 20:80 to 80:20, v/v) containing 0.5% (v/v) glacial acetic acid. The mobile phase was employing gradient elution at a flow rate of 1.0 ml/min. The method showed good linearity and no endogenous material interfered with the marked compounds and I.S. peaks. The limit of quantification of danshensu, ferulic acid, cryptotanshinone, and tanshinone IIA were 0.1, 0.03, 0.05, and 0.05 mu g/ml, respectively. The average extract recoveries of the four compounds from rabbit plasma were all over 60%. The precisions determined from 5 days were all within 10%. The established method has been successfully applied in the pharmacokinetic study and drug interaction of danshensu, ferulic acid, cryptotanshinone, and tanshinone IIA in rabbits after intravenous administration of danxiongfang, a useful compound preparation of traditional Chinese medicine. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:1106 / 1112
页数:7
相关论文
共 23 条
[1]  
CAO EH, 1996, ACTA BIOPHYS SIN, V12, P339
[2]  
Chen ML, 2005, CHIN J CLIN PHARM TH, V10, P586, DOI 10.3969/j.issn.1009-2501.2005.05.024
[3]  
CHEN WZ, 1984, ACTA PHARM SIN, V19, P876
[4]  
Chen WZ, 1979, ACTA PHARMACOL SINIC, V14, P277
[5]   The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis [J].
Elsharkawy, AM ;
Oakley, F ;
Mann, DA .
APOPTOSIS, 2005, 10 (05) :927-939
[6]  
Gao Y G, 1979, Yao Xue Xue Bao, V14, P75
[7]   Simultaneous quantification of cryptotanshinone and its active metabolite tanshinone IIA in plasma by liquid chromatography/tandem mass spectrometry (LC-MS/MS) [J].
Hao, HP ;
Wang, GJ ;
Li, P ;
Li, J ;
Ding, ZQ .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2006, 40 (02) :382-388
[8]   Ferulic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II [J].
Hou, YZ ;
Yang, J ;
Zhao, GR ;
Yuan, YJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 499 (1-2) :85-90
[9]   Protective effect of Ligusticum chuanxiong and Angelica sinensis on endothelial cell damage induced by hydrogen peroxide [J].
Hou, YZ ;
Zhao, GR ;
Yang, J ;
Yuan, YJ ;
Zhu, GG ;
Hiltunen, R .
LIFE SCIENCES, 2004, 75 (14) :1775-1786
[10]   Simultaneous determination of tanshinone IIA and cryptotanshinone in rat plasma by liquid chromatography-electrospray ionisation-mass spectrometry [J].
Li, J ;
Wang, GJ ;
Li, P ;
Hao, HP .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2005, 826 (1-2) :26-30